March 21, 2024 – Newfoundland and Labrador – Through Budget 2024, the Government of Newfoundland & Labrador is expanding its continuous glucose monitoring program to include patients with type 1 […]
JDRF Proudly Announces the Appointment of New International Board of Directors Vice Chair
Matt Varey of Ontario is the first Canadian to serve as Vice Chair on the board of the global type 1 diabetes non-profit New York and Toronto, March 13, 2024 […]
Canadians living with type 1 diabetes will have improved access to the treatments and devices they need through a new national pharmacare program
February 29, 2024 – Ottawa – Today marks a historic moment for the type 1 diabetes (T1D) community in Canada. JDRF Canada is thrilled to have been part of the […]
Nova Scotia announces expanded coverage for insulin pumps and advanced glucose monitoring
February 28, 2024 – Halifax – The Government of Nova Scotia announced a historic investment to provide better access to diabetes devices such as insulin pumps and glucose monitors for […]
Ensuring Canadians living with diabetes have access to the treatments and devices they need in Canada’s national pharmacare program
February 27, 2024 – Canada-wide – JDRF Canada, an organization dedicated to improving the lives of the estimated 300,000 Canadians living with type 1 diabetes (T1D) through its advocacy efforts, […]
CIHR Research Excellence, Diversity, and Independence (REDI) Early Career Transition Awards Announced
These awards support the career development of the next generation of health researchers. The REDI awards are available to post-doctoral researchers, clinicians, and research associates from specific underrepresented groups to […]
JDRF Canada Op-Ed in the Hill Times, February 14, 2024
OPINION: Canada is on track to cure type 1 diabetes. With the right support, we can get there. Research innovation is becoming increasingly competitive in the post-pandemic world and Canada […]
JDRF Canada and Sanofi Canada partner to raise awareness about autoimmune type 1 diabetes and the critical role of screening in its early detection.
Toronto, Ontario, February 20, 2024 – JDRF Canada and Sanofi Canada are announcing a partnership aimed at amplifying awareness around type 1 diabetes (T1D), a chronic autoimmune condition, and the […]
Statement from JDRF calling for a Medical Corridor in the Middle East
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, joins healthcare and humanitarian non-profits throughout the world in calling for a medical corridor to allow immediate access […]
JDRF Awards $12 Million for Phase 3 Type 1 Diabetes Kidney Disease Clinical Trial, Joins The Kidney Foundation of Canada in Driving Research to Treat Kidney Disease – JDRF
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has awarded $12 million to researchers Dr. Alessandro Doria with Joslin Diabetes Center, Dr. Michael Mauer with the […]
JDRF Canada is pleased to support 4 new trainees in partnership with the Canadian Islet Research and Training Network
JDRF Canada is thrilled to continue a successful partnership with the Canadian Islet Research and Training Network (CIRTN) and announce a second cohort of co-funded trainees beginning in 2024. CIRTN […]
JDRF Canada and Stem Cell Network announce second recipient of the J. Andrew McKee Fellowship in Type 1 Diabetes
October 23, 2023 (Ottawa/Toronto) – JDRF Canada and the Stem Cell Network are pleased to announce Dr. Sing-Young Chen as the 2023 J. Andrew McKee Fellow in Type 1 Diabetes (T1D). […]